Cargando…
Reovirus Type 3 Dearing Variants Do Not Induce Necroptosis in RIPK3-Expressing Human Tumor Cell Lines
Reoviruses are used as oncolytic viruses to destroy tumor cells. The concomitant induction of anti-tumor immune responses enhances the efficacy of therapy in tumors with low amounts of immune infiltrates before treatment. The reoviruses should provoke immunogenic cell death (ICD) to stimulate a tumo...
Autores principales: | van den Wollenberg, Diana J. M., Kemp, Vera, Rabelink, Martijn J. W. E., Hoeben, Rob C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916669/ https://www.ncbi.nlm.nih.gov/pubmed/36768641 http://dx.doi.org/10.3390/ijms24032320 |
Ejemplares similares
-
Exploring Reovirus Plasticity for Improving Its Use as Oncolytic Virus
por: Kemp, Vera, et al.
Publicado: (2015) -
Oncolytic Reovirus Infection Is Facilitated by the Autophagic Machinery
por: Kemp, Vera, et al.
Publicado: (2017) -
Roles of RIPK3 in necroptosis, cell signaling, and disease
por: Morgan, Michael J., et al.
Publicado: (2022) -
Isolation of Reovirus T3D Mutants Capable of Infecting Human Tumor Cells Independent of Junction Adhesion Molecule-A
por: van den Wollenberg, Diana J. M., et al.
Publicado: (2012) -
Preinduced reovirus-specific T-cell immunity enhances the anticancer efficacy of reovirus therapy
por: Groeneveldt, Christianne, et al.
Publicado: (2022)